Lifevantage Corporation, a health and nutrition company headquartered in Lehi, United States, operates within the Consumer Staples sector, specifically focusing on the Personal Care Products industry. The company is renowned for its development of dietary supplements aimed at combating oxidative stress, thereby supporting brain, eye, and joint function, as well as offering skin and canine products. Lifevantage’s product range is designed to promote good health and prevent various health issues.
The company’s stock is publicly traded on the Nasdaq stock exchange under the ticker symbol LFVN. As of March 8, 2026, Lifevantage’s closing price was $5.09. Over the past year, the stock has experienced significant volatility, with a 52-week high of $17.64 on March 16, 2025, and a 52-week low of $3.90 on February 4, 2026. This volatility is reflected in the company’s price-to-earnings ratio of 8.177, indicating a modest earnings power relative to its share price.
Lifevantage’s market capitalization stands at $62,431,592 USD, underscoring its position within the industry. The company’s financial metrics, including a price-to-book ratio of 1.82, suggest a valuation that is modest in comparison to its book value. Technical analysis indicates that Lifevantage’s stock has recently fallen below its 200-day moving average, a trend noted in a February 24, 2026, article by American Banking News. This movement could be indicative of a bearish sentiment among investors.
As of the latest updates, there have been no new press releases from Lifevantage, leaving the company’s public narrative unchanged since the February 24, 2026, report. For more detailed information about Lifevantage’s products and services, interested parties are encouraged to visit their official website at www.lifevantage.com .
